Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload
about
Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fractionRepair Injured Heart by Regulating Cardiac Regenerative SignalsMuscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injuryTherapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical modelsFollistatin-like 1 in vertebrate developmentIdentification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndromeMuscle as a secretory organ.Epicardial FSTL1 reconstitution regenerates the adult mammalian heart.Impaired elastin deposition in Fstl1-/- lung allograft under the renal capsule.Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice.The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-κB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation.Regulation of NAD(P)H oxidases by AMPK in cardiovascular systemsAssociation of Circulating Follistatin-Like 1 Levels with Inflammatory and Oxidative Stress Markers in Healthy MenThe expression and post-transcriptional regulation of FSTL1 transcripts in placental trophoblasts.Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exerciseFollistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection.Follistatin like 1 Regulates Hypertrophy in Heart Failure with Preserved Ejection FractionFollistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction Rats.Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice.Myokines in insulin resistance and type 2 diabetes.Follistatin-like protein 1 and its role in inflammation and inflammatory diseases.Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock.The AMPK Activator Aicar Ameliorates Age-Dependent Myocardial Injury in Murine Hemorrhagic Shock.Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy.The Correlation between FSTL1 Expression and Airway Remodeling in Asthmatics.Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.Obesity-induced kidney injury is attenuated by amelioration of aberrant PHD2 activation in proximal tubulesRegulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells.Effect of Omega-3 Polyunsaturated Fatty Acids Supplementation on Body Composition and Circulating Levels of Follistatin-Like 1 in Males With Coronary Artery Disease: A Randomized Double-Blind Clinical Trial.Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.Cardiomyokines from the heart.Unravelling the effects of mechanical physiological conditioning on cardiac adipose tissue-derived progenitor cells in vitro and in silico.Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans.Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress.The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?Follistatin-like 1 in development and human diseases.Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO.
P2860
Q26853363-DF5593FD-C848-4F80-BA2B-FF00DADEC410Q28066930-C5E87EC0-B24A-4356-8FA7-AAF1012D7A33Q28238431-7184F443-490E-449A-8416-688BCB038370Q28273799-F5F2DA03-010A-4977-A29F-3FF14EE63A18Q28291738-56A5BA8E-99F8-448B-B273-33FDB31B2F41Q34032238-F1AC2F9A-DD95-455E-A4EA-047262DF901AQ34360586-3C120C83-2775-4997-93D5-94735332D96AQ34494355-F3EF0F4B-BFB4-43C3-93C8-7FF881A4C721Q35055283-2ECBF0A0-7D60-4754-83D9-F48F82AB2D5FQ35064880-2E4AEE85-21F6-4C50-8658-6B0EAC82790BQ35530208-A2ACAE47-7A4C-4400-99B8-2006059B9937Q35925959-38B5B6F1-17AA-40CB-B537-25817E636B97Q36008387-32294CC0-31B1-418F-97F3-07DB328F7250Q36278850-522EEED0-A8A2-4EED-8811-BFC04625A434Q36939096-1D2A2DE8-B074-4608-B56F-D18570913199Q36986322-A4C9CED3-5F55-4B44-9628-DF16FC594CF3Q37094365-9246279C-A192-4E06-AD24-6897C6A90B87Q37141388-DFD9D40D-3562-4F6F-BCC6-CBE53653616FQ37209367-A7E8C731-6A9B-499F-9E44-97BA8BC5A8DBQ37731385-B522D6A6-41D7-4992-8B45-34EF2721509BQ38199992-E8828739-5560-4132-9F10-332ED6147A02Q38212545-6873B798-602B-4429-BABA-D6BB2BB965AFQ38745586-488586B4-3C42-4A70-B593-2051CD1B0C35Q39500637-9B39A481-E361-4E2C-A10C-36FAE66140CFQ40042810-584C02B0-AFE3-47BF-A484-73D1B234DCE5Q41440735-DCF087E6-B434-45C1-B21E-ED4391458203Q42136100-8E267458-4B91-4899-99C6-8055E122418DQ42371719-2213AB0D-033A-4483-A3E3-B3D258139A1DQ45892533-F7F31080-FB27-4411-8CC0-1E2FCE5AA3E2Q47103905-C63B1265-6A6D-41E4-8D99-FD2BBCB449ADQ47215993-0124C00B-7977-493F-B9E4-44D5AD31F05EQ47916949-5EC81713-7130-46E1-80BB-321A0FD26EAAQ49178138-E74B8A25-A558-40EA-881A-7AAF6FC776E5Q49484266-56720A8B-EDD6-481A-A314-BFA8B71F544FQ52730911-B2E3DD95-D2AB-4187-9777-B79152D9D47BQ53095486-32A4C222-9311-4AFB-998F-10C9A2875A46Q53699115-597FE103-1C8D-4DEB-A4E7-ED9C61CAE2BAQ55140242-33A5E317-419F-46F2-8E73-4A0F8B61979DQ55294487-72E17132-E792-447A-A9CA-3C75B89425A9
P2860
Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cardiac myocyte follistatin-li ...... hy following pressure overload
@ast
Cardiac myocyte follistatin-li ...... hy following pressure overload
@en
Cardiac myocyte follistatin-li ...... hy following pressure overload
@nl
type
label
Cardiac myocyte follistatin-li ...... hy following pressure overload
@ast
Cardiac myocyte follistatin-li ...... hy following pressure overload
@en
Cardiac myocyte follistatin-li ...... hy following pressure overload
@nl
prefLabel
Cardiac myocyte follistatin-li ...... hy following pressure overload
@ast
Cardiac myocyte follistatin-li ...... hy following pressure overload
@en
Cardiac myocyte follistatin-li ...... hy following pressure overload
@nl
P2093
P2860
P50
P3181
P356
P1476
Cardiac myocyte follistatin-li ...... hy following pressure overload
@en
P2093
Akiko Higuchi
Bram van Wijk
Kazuto Nakamura
Koji Ohashi
Masayuki Shimano
Maurice J B van den Hoff
Noriyuki Ouchi
Toyoaki Murohara
P2860
P304
P3181
P356
10.1073/PNAS.1108559108
P407
P577
2011-10-25T00:00:00Z